Cargando…
A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
The prevalence of chronic viral infectious diseases, the emergence and re-emergence of new viral infections, and in particular, resistance to currently used antiviral drugs have led to increased demand for new antiviral strategies and reagents. Increased understanding of the molecular mechanisms of...
Autores principales: | Cao, Lin, Zhu, Shouhai, Wang, Yaxin, Lou, Zhiyong, Sun, Yuna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762143/ https://www.ncbi.nlm.nih.gov/pubmed/26942222 http://dx.doi.org/10.1007/s41048-015-0006-z |
Ejemplares similares
-
Erratum to: A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
por: Cao, Lin, et al.
Publicado: (2016) -
Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71
por: Dang, Minghao, et al.
Publicado: (2014) -
Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020) -
The discovery of antivirals and novel targets for SARS-CoV-2 and EV-A71
por: Haddad, Christina, et al.
Publicado: (2022) -
Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)